期刊文献+

针药结合治疗寒湿痹阻型膝骨性关节炎临床观察 被引量:3

Clinical Observation on Acupuncture Combined with Chinese Medication Treating Knee Osteoarthritis with Cold-Dampness Impedingls Syndrome
下载PDF
导出
摘要 目的:观察针刺结合口服独活寄生汤对寒湿痹阻型膝骨关节炎的的近期疗效。方法:将72例符合寒湿痹阻型膝骨关节炎患者随机分为观察组与对照组,每组各36例.观察组采用针刺和口服中药的方法治疗。针刺以疼痛局部取穴为主并配合口服独活寄生汤辨证加减治疗,治疗1次/d,连续治疗6次为1疗程,疗程间休息1d;对照组给予口服美洛昔康片7.5mg,1次/d,2组均治疗4周后进行骨性关节炎指数(WOMAC)量表评分判定。结果:2组患者治疗4周后,观察组WOMAC疼痛、僵硬和关节功能评分均低于对照组(P<0.05)。观察组总有效率为91.67%;优于对照组的83.33%。2组对比,差别有统计学意义(P<0.05)。结论:针刺结合口服独活寄生汤治疗寒湿痹阻型膝骨关节炎能减轻疼痛,缓解僵硬以及改善生理功能,近期疗效显著。 Objective: To observe the short-term effect of acupuncture combined with oral bourgeois decoction on arthritis of cold and dampness-type knee osteoarthritis. Methods: 72 patients with knee arthritis were randomly divided into observation group and control group, 36 cases in each group. The observation group was treated by acupuncture and oral Chinese medicine. Acupuncture to the pain of local acupoints and with the oral Duhuo Jisheng decoction plus or minus treatment, treatment 1 / d, continuous treatment 6 times for a course of treatment, rest ld; the control group given oral meloxicam tablets 7.Smg, Once / d, 2 groups were treated for 4 weeks. After 4 weeks, the osteoarthritis index (WOMAC) scale was used to determine the score. Results: After 4 weeks of treatment, WOMAC pain, stiffness and joint function score of the observation group were lower than those of the control group (P〈0.05). The total effective rate of the observation group was 91.67%, which was better than that of the control group (83.33%). The difference between the two groups was statistically significant (P〈0.05). Conclusion: Acupuncture combined with oral administration of Duhuo Jisheng decoction can treat pain, relieve stiffness and improve physiological function, and the curative effect is remark- able in the treatment of knee osteoarthritis.
作者 王军 WANG Jun(Dongwan Health Center of Jingyuan Country,Gansu Jingyuan 730606,China)
出处 《中医药临床杂志》 2017年第2期225-227,共3页 Clinical Journal of Traditional Chinese Medicine
关键词 针药结合 寒湿痹阻型 膝关节骨性关节炎 Acupuncture combined with medicine, cold and dampness-type syndrome, knee osteoarthritis
  • 相关文献

参考文献4

二级参考文献68

  • 1Inotai A, Hanko B, Meszaros A. inflammatory drug market in Trends in the non-steroidal anti six Central-Eastern European countries based on retail information [J]. Pharmacoepidemiol Drug Saf,2010,19(2 ) : 183.
  • 2Muller N. COX-2 inhibitors as antidepressants and antipsychotics : Clinical evidence[ J]. Curr Opin Invest Drugs,2010,11:31.
  • 3Rao PNP, Rajesh KG. Apricoxib, a COX-2 inhibitor for the potential treatment of pain and cancer [ J ]. I Drugs, 2009, 12 (11) :711.
  • 4Biava M, Porretta GC, Poce G, et al. Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation [J]. J Med Chem,2010 ,53 (2) :723.
  • 5Renard JF, Arslan D, Garbaeki N, et al. Pyridine analogues of nimesulide : design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors [ J ]. J Med Chem, 2009,52 ( 19 ) :5864.
  • 6Wallace JL, Ignarro LJ, Fiorucci S. Potential eardioprotective actions of no-releasing aspirin [ J ]. Nat Rev Drug Discov, 2002,1(5) :375.
  • 7Velazquez CA, Chen QH, Citro ML, et aL Second-generation aspirin and indomethacin prodrugs possessing an 0 ( 2 ) -( acetoxymethyl) -1 -( 2-carboxypyrrolidin-1 -yl ) diazenium-1,2-diolate nitric oxide donor moiety : design, synthesis, biological evaluation, and nitric oxide release studies [ J ]. J Med Chem, 2008, 51 (6) :1954.
  • 8Lazzarato L, Donnola M, Rolando B, et al. ( Nitrooxyacyloxy ) methyl esters of aspirin as novel nitric oxide releasing aspirins [ J ]. J Med Chem,2009,52 ( 16 ) : 5058.
  • 9Dailey LA, Imming P. 12-Lipoxygenase : classification, possible therapeutic benefits from inhibition, and inhibitors [ J ]. Curt Med Chem, 1999,6 ( 5 ) : 389.
  • 10Reddy MV, Billa VK, Pallela VR, et al. Design, synthesis, and biological evaluation of 1-( 4-sulfamylphenyl ) -3-trifluoromethyl-5indolyl pyrazolines as cyclooxygenase-2 ( COX-2 ) and lipoxygenase (LOX) inhibitors [ J 1. Bioorg Med Chem, 2008, 16 (7) :3907.

共引文献260

同被引文献62

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部